Ann: Quarterly Activities Report & Appendix 4C, page-4

In regards to customer receipts, that makes sense, thanks for the heads up.

The $300k I believe was over the lifetime of both products, “along with sales of Cresos animal health product, anibidiol, following the launch of that product” and was on the ann released 27/2 so includes up to this date not just Q4 2017. I’m still confused as to when CannaQIX was actually launched which seems to have contributed to the majority of revenue, do you know?